Oneok upgraded at Wolfe Research, saying the stock has fallen out of favor on near-term Bakken headwinds and its valuation has quickly shifted to a big discount to large-cap peers.

Wolfe Research reaffirmed its Outperform rating and $108.00 price target for Okta, Inc (NASDAQ:OKTA), coinciding with Okta's announcement of leadership changes. The cybersecurity company, currently ...

Wolfe Research reiterated its Outperform rating on Charles Schwab Corporation (NYSE:SCHW), a $148 billion financial services giant with an impressive 96.99% gross profit margin, maintaining a steady ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

Consumer downloads of apps like Cash App and Venmo dropped in the fourth quarter compared to the year-ago period, data from ...

Wolfe Research initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $19 price target After its IPO in September 2024, ...

Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is bullish on the stock ...

Investing.com - U.S. President Donald Trump's decision to impose tariffs on America's closest trading partners means that ...

Aptiv PLC (NYSE: APTV), a global technology company focused on enabling a more safe, green and connected future, will present at Wolfe Research Auto, Auto Tech and Semiconductor Conference, February ...